Cellarity to Present at the 42nd Annual J.P. Morgan Healthcare Conference
Cellarity Inc., a life sciences company founded by Flagship Pioneering to fundamentally transform the way drugs are created and design medicines currently out of reach, announced today that Fabrice Chouraqui, CEO of Cellarity, will present a company overview, including recent business and research highlights, at the 42nd Annual J.P. Morgan Healthcare Conference at the Westin St. Francis on Thursday, January 11, 2024, at 7:30 a.m. PT.
A copy of the company's presentation will be made available on the company's website following the event.
About Cellarity
Cellarity is fundamentally redesigning the way drugs are created. By shifting our scientific focus from a single target to the underlying cellular dysfunction, the company unravels the complexity of disease biology to create medicines that are out of reach with a target-based drug discovery approach. Founded by Flagship Pioneering in 2017, Cellarity has developed a platform that utilizes proprietary AI models trained on over 30 million single cell transcriptomes to uncover novel actionable biology and create non-intuitive drug candidates in a vast array of diseases. The company currently has programs ongoing in several disease areas including metabolic disease, hematology, and immunology. For more information, visit www.cellarity.com.
In a heartfelt message in the heart of spring, Kevin Guest, executive chairman at USANA Health Sciences , shares his insights and support for May's Family Wellness Month, an initiative that highlights the importance of family health and unity....
10 Barrel Brewing Co. ("10 Barrel Brewing Co." or "10 Barrel"), a Pacific Northwestern pioneer in craft brewing, a subsidiary of Tilray Brands, Inc. , unveils its latest creation: Pub Cerveza. Building upon the legacy of the ?Cheap Fun.' family,...
Fulgent Genetics, Inc. ("Fulgent," or the "Company"), a technology-based company with a well-established laboratory services business and a therapeutic development business, today announced financial results for its first quarter ended March 31,...
2seventy bio, Inc. will announce its first quarter 2024 financial results on Wednesday, May 8, 2024. A conference call and webcast will be held at 8:00 a.m. ET.
Participants can access the conference call live via webcast which will be available...
Castle Biosciences, Inc. , a company improving health through innovative tests that guide patient care, today announced that new data supporting the utility of its DecisionDx-SCC test in patients with high-risk cutaneous squamous cell carcinoma (SCC)...
Cipher Pharmaceuticals Inc. ("Cipher" or the "Company") today announced that it will release its financial results for the first quarter of 2024 after the market close on Thursday, May 9, 2024. The Company will also hold a conference call on...
